KANCERA AB Aktie - Unternehmensdaten & Kurse - SE0015658570 | MoneyPeak

KANCERA AB

Share · SE0015658570 · A2QQQ4 (XSTO)

No Price

n/a

Share Float & Liquidity

Free Float 90,41 %

Shares Float 109,57 M

Shares Outstanding 121,19 M

Company Profile for KANCERA AB Share

Kancera AB (Publ) develops drugs for inflammatory diseases and cancer in Sweden and internationally. The company is developing small molecule drug candidates KAND567, which is in phase IIa clinical trial for inflammatory heart disease following infarction, as well as KAND145, which is in phase I study in healthy subjects to document desired dose levels against cancer; and Phase IIa study for the treatment of ovarian cancer. It also develops HDAC for the treatment of nerve inflammation and pain; and ROR1 inhibitors for the treatment of solid tumors and blood cancers. Kancera AB (Publ) was founded in 2010 and is based in Solna, Sweden.

Get up to date insights from finAgent about KANCERA AB

Company Data

Name KANCERA AB

Company Kancera AB (publ)

Website https://www.kancera.com

Primary Exchange

NASDAQ STOCKHOLM AB

WKN A2QQQ4

ISIN SE0015658570

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Peter Selin

Market Capitalization 36 Mio

Country Sweden

Currency SEK

Employees 0,0 T

Address Karolinska Institutet Science Park, 171 65 Solna

IPO Date 2011-02-25

Ticker Symbols

Name	Symbol
NASDAQ STOCKHOLM AB	KAN.ST
Frankfurt	3EE0.F

More Shares

Investors who hold KANCERA AB also have the following shares in their portfolio:

Beyon3D Ltd. Share

SEMAPA SGPS NAM. Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025